It is suggested that the inflammation-induced aggregation of CGCs in the vicinity of cardiac VGLUT1 nerves in the early stage of CHF may be a compensatory response to control cardiac lipid metabolism impairment. This evidence concerns the gene SLC17A7 and congestive heart failure.